What are the long term risks of stem cell therapy is a question worth asking before you decide on any regenerative treatment. Stem cell therapy is still considered investigational by the FDA for most uses, which means the long term effects are not fully established. Some people look into these injections for knee pain, arthritis symptoms, or to try to delay surgery, but the real risks include uncertain benefit, delayed care if a serious joint problem is missed, procedure-related complications, and the possibility that an unproven product may not match what was advertised. In Florida, where arthritis affects 24% of adults, about 5.2M people, it is especially important to weigh evidence, cost, and safety carefully before moving forward. This guide explains what is known, what is not known, and how to make a more informed decision.
What are the long term risks of stem cell therapy?
The biggest long term risk is uncertainty. Years after stem cell treatment, you may still not know whether any improvement came from the injection, natural symptom fluctuation, or other care. Other risks include infection, inflammation, pain at the injection site, and missed diagnosis if the underlying knee problem is not properly evaluated first. Because these therapies are investigational for most uses, long term safety data remain limited.
ContextWhat stem cell therapy long term effects are actually known?
The long term effects that are best documented are not dramatic cures, but mixed and incomplete outcomes. Some people report temporary symptom relief, while others notice no meaningful change. There is also the concern that an unregulated or poorly characterized product may vary from one clinic to another. That makes follow-up important, especially if your pain, swelling, or mobility changes after treatment.
EvidenceWhat does the evidence say about long term stem cell risks?
A Cochrane 2025 systematic review included 25 trials and 1,341 participants, and the overall evidence did not establish dependable long term benefit for knee osteoarthritis. The FDA also notes that many regenerative products are being marketed without full approval for orthopedic uses. That matters because short-term marketing claims can sound persuasive, but they do not replace strong clinical evidence.
CostHow much do stem cell injections cost for a knee?
Regenerative injection cost is commonly $3,000 to $8,000 per knee, and insurance often does not cover it when the therapy is considered investigational. That means the financial risk is real if the treatment does not help enough to justify the expense. Before paying out of pocket, compare the likely benefits, the quality of the evaluation, and what other evidence-based options exist.
Next StepWhat should you do next if you are considering treatment?
If you are weighing stem cell therapy, start with a proper knee evaluation so you understand the cause of your pain and the options available. At Revive by MWS in Leesburg, you can ask about a free knee screening to help you discuss symptoms, movement limits, and next steps. A thoughtful evaluation can reduce the chance of overlooking a problem that needs different care.
Key FactsKey Facts to Remember
Book Your Free Knee Screening
The free knee screening is available to a limited number of qualifying patients each month at Revive by MWS, 920 E Dixie Ave Suite A, Leesburg, FL 34748. Includes imaging review, physical exam, and a clear conversation about whether regenerative therapy fits your case.
Common Questions
It can. The main long term concern is less about a proven delayed complication and more about uncertainty, because most orthopedic uses do not have strong long-term safety data. If symptoms return, worsen, or change after treatment, you should get a medical evaluation rather than assuming the injection failed or succeeded.
Current evidence does not show dependable long term results for knee arthritis. Some people report symptom improvement, but studies have not confirmed consistent benefit across patients. That is why it is important to treat stem cell therapy as investigational and not as a substitute for a careful diagnosis and evidence-based planning.
The biggest risks are limited durability of benefit, missed or delayed treatment of the real problem, and complications such as pain, swelling, or infection related to the procedure. Another risk is paying a high out-of-pocket cost for a therapy that does not provide enough improvement to justify it.
For most orthopedic and arthritis uses, regenerative cell therapies are not FDA-approved as established treatments. The FDA has warned consumers about unapproved products and misleading claims. That means you should ask exactly what product is being used, how it is sourced, and what evidence supports it.
You start by confirming the cause of your pain and how severe the joint damage is. If your symptoms are mild or moderate, non-surgical options may still help. If your knee is badly worn down, you may need a different plan. A screening visit can help you sort that out.
Sources
Education only. Not medical advice. Regenerative injections for knee osteoarthritis are not FDA-approved and are considered investigational. Individual results vary. Consult a licensed medical provider about your specific case.